I'd go with the preso Muddy. The website is notoriously incorrect and out of date. It's Nant Capital, not Nant itself, that he work(ed?) for.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025